A longtime client of That’s Nice, UPM Pharmaceuticals is utilizing a number of research, content and communications channels to drive leads and promote continued expansion. View Case Study >
New Client Case Study - Avara Pharmaceutical Services
October 2, 2017
Avara is continuing to expand its world-class CDMO services with the addition of three new global facilities, and That's Nice is working hard to ensure the brand's reputation for excellence remains at the forefront of its communications. View Case Study >
New Case Studies - Nice Short
May 19, 2017
That's Nice is pleased to showcase some of the exciting video animation work we've produced for our life science clients across the industry. View case studies >
New Client Case Study – Unither Pharmaceuticals
May 11, 2017
After expanding into the North American market, Unither Pharmaceuticals worked with That’s Nice to develop brand equity and support the launch of new technologies in the US. View Case Study >
New client case study launches – CMC Biologics
March 31, 2017
Seeking to further differentiate its capabilities within the biopharmaceutical CDMO market, CMC Biologics engaged us to help convey its experience, flexibility, and innovation in delivering ‘right-on-time’ solutions. View Case Study >
New client case study launches – Servier CDMO
March 29, 2017
Leveraging its 11 global facilities, Servier Laboratories developed an embedded CDMO business and engaged That’s Nice to help market the company’s excess capacity to other pharmaceutical manufacturers. View Case Study >
New client case study launches – Cenexi
March 29, 2017
That’s Nice worked with Cenexi to optimize awareness of the brand’s robust CDMO business and sterile oncology capabilities while emphasizing the company’s history of innovation. View Case Study >
New client case study launches – Icagen
March 28, 2017
Following a series of organizational changes resulting in an expansion of both space and capacity, That’s Nice worked with Icagen to create a unified brand that wholly conveyed the company’s robust capabilities in early discovery. View Case Study >